|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Revenue | ||
| Product, net | ||
| Licensing | ||
| Total revenue | ||
| Operating Expenses | ||
| Cost of product sales, excluding amortization of intangible asset | ||
| Cost of licensing revenue | ||
| Amortization of intangible asset | ||
| Research and development | ||
| General and administrative expenses | ||
| Total operating expenses | ||
| Selling, general and administrative expenses | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other income (expenses) | ||
| Foreign exchange (loss) gain | ||
| Interest income | ||
| Grant income | ||
| Interest expense | ||
| Impairment of intangible assets | ||
| Loss on derivative liabilities and conversion of convertible debt | ||
| Provision for loan losses | ||
| Gain (loss) on derivative liabilities and conversion of convertible debt | ||
| Other expenses | ||
| Total other income (expenses) | ||
| Net loss and comprehensive loss | ||
| Comprehensive loss | ||
| Weighted average stock outstanding, basic (in Shares) | ||
| Net loss per share, basic (in Dollars per share) | ||
| Adjusted net loss, diluted | ||
| Weighted average stock outstanding, diluted (in Shares) | ||
| Net loss per share, diluted (in Dollars per share) |
Loading...
